Federal Circuit / U.S. Court of Spec. Jurisdiction

Published between:
Published Title Organization
Jun
24
2021
In United States v. Arthrex, Supreme Court Holds Administrative Patent Judges’ Decisions Must Be Reviewed by the Director of the U.S. Patent and Trademark Office Greenberg Traurig, LLP
Jun
24
2021
Federal Circuit Lacks Appellate Jurisdiction over Standalone Walker Process Claims McDermott Will & Schulte LLP
Jun
24
2021
Diehr Alice, Yu are Superimposing Novelty onto Patent Eligibility. Love, Newman. McDermott Will & Schulte LLP
Jun
23
2021
Honesty is the Best Policy: Federal Circuit Affirms Vacatur of Judgment Due to Material Misrepresentations Proskauer Rose LLP
Jun
21
2021
A Fractured Vision of Eligibility — Split Federal Circuit Panel Finds Digital Camera Claims Ineligible Finnegan
Jun
17
2021
SCOTUS to Consider Intent-to-Defraud Requirement for Copyright Registration Invalidation Finnegan
Jun
17
2021
How Many Communications Before a State Has Jurisdiction? Proskauer Rose LLP
Jun
17
2021
Applicant’s Unreasonable Delays During Patent Prosecution Can Lead to Prosecution Laches Finnegan
Jun
15
2021
Statements Made in Litigation Can Support Prosecution History Estoppel Finnegan
Jun
14
2021
Yu v. Apple – Transubstantiation of a Camera into an Abstract Idea Schwegman, Lundberg & Woessner, P.A.
Jun
10
2021
What You Say Can and Will be Used Against You – Prosecution History and Prior Infringement Arguments McDermott Will & Schulte LLP
Jun
10
2021
Submarine Sunk: Patent Prosecution Laches Pops GATT Bubble McDermott Will & Schulte LLP
Jun
4
2021
Will the Real Inventor(s) Please Stand Up Finnegan
Jun
3
2021
Failing to Adequately Support a Means-Plus-Function Claim Term Renders a Claim Invalid Mintz
Jun
3
2021
Speak Now or Forever Hold Your Peace - Avoiding Future Estoppel Challenges Finnegan
Jun
3
2021
It’s Highlighted and Verified: Reversal of PTAB Non-Obviousness Decision McDermott Will & Schulte LLP
May
27
2021
Spotlight on Upcoming Oral Arguments – June 2021 Finnegan
May
27
2021
Biogen v. Serano – When is a Recombinant Polypeptide Novel? Schwegman, Lundberg & Woessner, P.A.
May
27
2021
Patent Owner Tip #8 for Surviving an Instituted IPR: Additional Discovery is Possible, but Should be Carefully Planned Mintz
May
27
2021
Not With a Bang but a Whimper McDermott Will & Schulte LLP
May
27
2021
Forum Shopping: How A Retailer’s Patent-Related Communications May Impact Jurisdiction Hunton Andrews Kurth
May
26
2021
Trial & Error: Violation of MIL Order Not a Per Se Justification for New Trial Squire Patton Boggs (US) LLP
May
23
2021
Hello Again, Worlds: A Failed Gaming IPR Leads to § 101 Success Sheppard, Mullin, Richter & Hampton LLP
May
20
2021
When Cease-and-Desist Letters Create a Risk of a Declaratory Judgment Backlash: Observations from Trimble Inc. v. PerDiemCo LLC Squire Patton Boggs (US) LLP
May
20
2021
Federal Circuit PTAB Appeal Statistics Through April 30, 2021 Finnegan
May
20
2021
Arthrex Argument May Be Available in Round Two McDermott Will & Schulte LLP
May
20
2021
Prosecution History Prevents Patent Owner from “Intercepting” Win on Appeal McDermott Will & Schulte LLP
May
20
2021
New Vision Wins Another Chance to Defend Gaming Patents Following Arthrex Remand Finnegan
May
20
2021
New Perspective on Specific Personal Jurisdiction in Patent DJ Venue McDermott Will & Schulte LLP
May
20
2021
Full Scope of Claimed Invention Must Be Enabled McDermott Will & Schulte LLP
May
20
2021
Targeted Advertising Still Patent Ineligible Subject Matter McDermott Will & Schulte LLP
May
19
2021
Federal Circuit Affirms PTAB’s Claim Construction and Obviousness Analysis for VoIP Patent Finnegan
May
17
2021
Federal Circuit Reaffirms Targeted Advertising Is an Abstract Concept Finnegan
May
17
2021
Part 2: Prosecution History Under the Doctrine of Equivalents Finnegan
May
17
2021
License Agreement Not Enough for Standing on Appeal of an IPR Apple Inc. v. Qualcomm Inc. Foley & Lardner LLP
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters